Pharmacokinetics of bupivacaine enantiomers during interpleural infusion.
Interpleural infusions (24 hr) were given to 14 adults (29-81 yr) having surgery via right subcostal incisions. Patient-controlled analgesia with morphine was also available for 72 hours following surgery. An infusion of 0.25% bupivacaine with adrenaline 1/400,000 was commenced at 0.1 ml/kg/hr at the conclusion of surgery after an initial 20 ml bolus. The 24 hr cumulative morphine dose increased by 62% (P < 0.01) on the second postoperative day after the bupivacaine infusion was ceased, but the pain score did not change. There was no clinical evidence of bupivacaine toxicity although the maximum bupivacaine concentration ranged from 0.74-6.52 mg/l, mean 2.90 (SEM 0.44) mg/l and vascular uptake was rapid in two patients. The concentration of S-bupivacaine was consistently greater than R-bupivacaine (P < 0.05) and total body clearance was less. The unbound bupivacaine fraction also changed from 3.6% (SEM 0.6) at the start of the infusion to 2.0% (SEM 0.3) at 24 hr (P < 0.005). The total body clearance of each enantiomer was reduced during the 24 hours (P < 0.001). No relationship between pharmacokinetic parameters and weight, age or sex was found (P > 0.25 for each). Variation between patients was reduced when parameters were estimated for the free (unbound) bupivacaine (P < 0.001).
Blake
D W
DW
Department of Anaesthesia, Royal Melbourne Hospital, Parkville, Victoria.
Bjorksten
A
A
Dawson
P
P
Hiscock
R
R
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000698:Analgesia / Q000379:methods*; D016058:Analgesia, Patient-Controlled; D001652:Bile Ducts / Q000601:surgery; D001798:Blood Proteins / Q000378:metabolism; D002045:Bupivacaine / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D007267:Injections; D008099:Liver / Q000601:surgery; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage; D010149:Postoperative Pain / Q000517:prevention & control; D010994:Pleura; D011485:Protein Binding; D013237:Stereoisomerism
D001798:Blood Proteins; D009020:Morphine; D002045:Bupivacaine